Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00988338 · ClinicalTrials.gov registry record
Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion
A clinical trial, sponsored by Orthofix.
- Completed
- Registry status
- 106
- Enrollment target
NCT00988338: Completed study, sponsored by Orthofix.
NCT00988338 is a clinical trial that has completed, run by Orthofix. The registered enrollment target is 106 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00988338 has completed, sponsored by Orthofix.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The purpose of this study is to utilize Trinity Evolution as a graft source in foot/ankle fusions and to follow the subjects to measure the clinical outcomes and fusion rate. The hypothesis of the study is that Trinity Evolution will result in fusion rates and clinical outcomes similar to those obtained from autograft and other routinely used allograft materials; these include: fusion, improvement in pain, improvement in function, and absence of adverse events related to the use of the graft source.
Interventions
- BIOLOGICAL Trinity Evolution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-01 |
What the finished NCT00988338 record still lists
NCT00988338 is an observational study that tracks outcomes without assigning an intervention. The registered 106 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Trinity Evolution is the first listed.
NCT00988338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00988338 about?
NCT00988338 is a clinical study titled "Evaluation of Trinity Evolution in Patients Undergoing Foot and Ankle Fusion". The purpose of this study is to utilize Trinity Evolution as a graft source in foot/ankle fusions and to follow the subjects to measure the clinical outcomes and fusion rate. The hypothesis of the study is that Trinity Evolution will result in fusion rates and clinical outcomes similar to those obta...
What is the current status of trial NCT00988338?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2009-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00988338?
The interventions under investigation include: Trinity Evolution (BIOLOGICAL).
Who is sponsoring clinical trial NCT00988338?
This trial is sponsored by Orthofix, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03181048 · 106 participants · NA
Clinical Trial of Concomitant Hip Arthroscopy During PAO
- NCT04682158 · 106 participants · Phase 2
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
- NCT04724018 · 106 participants · Phase 1
Sacituzumab Govitecan Plus EV in Metastatic UC
- NCT04798274 · 106 participants · NA
Role of GABAergic Transmission in Auditory Processing in Autism Spectrum Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia